Adjunctive intravenous immunoglobulins (IVIg) for moderate-severe COVID-19: emerging therapeutic roles

Curr Med Res Opin. 2021 Jun;37(6):903-905. doi: 10.1080/03007995.2021.1903849. Epub 2021 Mar 31.
No abstract available

Publication types

  • Editorial